1. Stocks
    2. /
  2. Ebos Group Ltd (ASX: EBO)
    3. /

Ebos Group Ltd (ASX: EBO) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ebos Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $6.45 billion
P/E Ratio 23.69
Dividend Yield 2.93%
Shares Outstanding 194.68 million
Earnings per share 1.544
Dividend per share 1.01
Year To Date Return 4.02%
Earnings Yield 4.22%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Ebos Group Ltd (ASX: EBO)
    Latest News

    A woman holds her finger to the side of her lips in contemplation as she looks upwards to an array of graphic images of light bulbs above her head, one of which is on and glowing.
    Investing Strategies

    'Stock is oversold': 5 ASX shares to buy now before resurgence

    | Tony Yoo

    Check out these Best Idea gems from Morgans in the chaos of reporting season.

    Read more »

    A man reacts with surprise when her see a bargain price on his phone.
    Earnings Results

    3 ASX 300 shares going gangbusters on stellar earnings results

    | Bronwyn Allen

    These ASX 300 shares are well into the green today amid their full-year reports.

    Read more »

    A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
    Share Fallers

    Why ASX, Baby Bunting, Bowen Coking Coal, and EBOS shares are sinking today

    | James Mickleboro

    These ASX shares are falling heavily on Tuesday.

    Read more »

    a man smiles broadly as he holds up five fingers on one hand and two fingers on the other hand.
    Broker Notes

    7 more ideas for buying ASX shares this reporting season: expert

    | Tony Yoo

    The superpowers might be jostling for the new world order and the global economy might be on the brink, but…

    Read more »

    a person stands on top of a mountain with hands raised above their head gazing on an amazing sunrise over the landscape and above the clouds.
    52-Week Highs

    5 ASX All Ords shares cracking new 52-week highs on Tuesday

    | Brooke Cooper

    Are your investments trading at their highest point in more than 12 months today?

    Read more »

    A man looks surprised as a woman whispers in his ear.
    Share Market News

    5 profitable ASX shares you probably have never heard of

    | Mitchell Lawler

    This one might broaden your horizons.

    Read more »

    Four people on the beach leap high into the air.
    Healthcare Shares

    This ASX All Ordinaries share shrugged off the red to reach a new 52-week high today

    | Monica O'Shea

    We take a look at an All Ordinaries share that outperformed the index, and itself, today.

    Read more »

    Three healthcare workers standing together and smiling.
    Earnings Results

    Here are 3 ASX healthcare share results you might have missed

    | Raymond Jang

    Regis Healthcare, EBOS and Neuren Pharmaceuticals are three ASX healthcare shares that just posted results. Here is what you need…

    Read more »

    A group of business people pump the air and cheer.
    Share Market News

    Here are the top 10 ASX shares today

    | Brooke Cooper

    These are your biggest gainers to end the week.

    Read more »

    Contented looking man leans back in his chair at his desk and smiles.
    Broker Notes

    Why this $7 billion ASX-listed company is a 'hidden gem': expert

    | Tony Yoo

    This business supplies Chemist Warehouse, which is a giant that's still rapidly growing. And Australians still need pharmaceuticals regardless of…

    Read more »

    high, climbing, record high
    Capital Raising

    Here's why the EBOS (ASX:EBO) share price is climbing today

    | Aaron Teboneras

    The company's shares are on the move...

    Read more »

    A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
    Mergers & Acquisitions

    EBOS (ASX:EBO) share price on watch amid cap raise and $1 billion acquisition

    | Brooke Cooper

    EBOS announced a major acquisition this morning. Here are all the details.

    Read more »

    Frequently Asked Questions

    Yes, EBOS Group has historically paid two partially franked shareholder dividends a year.

    EBOS Group generally pays its shareholder dividends in March and September. 

    Yes, EBOS has a dividend reinvestment plan to allow shareholders to reinvest all or part of their dividends.

    EBOS Group Ltd listed on the ASX on 6 September 2013.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    29 Aug 2024 $0.5043 0.00% Final 18 Sep 2024
    29 Feb 2024 $0.1510 0.00% Supplemental 22 Mar 2024
    07 Sep 2023 $0.0251 0.00% Supplemental 29 Sep 2023
    07 Sep 2023 $0.4705 0.00% Final 29 Sep 2023
    02 Mar 2023 $0.0234 0.00% Supplemental 17 Mar 2023
    02 Mar 2023 $0.4259 0.00% Interim 17 Mar 2023
    08 Sep 2022 $0.0216 0.00% Supplemental 30 Sep 2022
    08 Sep 2022 $0.3800 0.00% Final 30 Sep 2022
    03 Mar 2022 $0.0207 0.00% Supplemental 18 Mar 2022
    03 Mar 2022 $0.3917 0.00% Interim 18 Mar 2022
    09 Sep 2021 $0.0203 0.00% Supplemental 24 Sep 2021
    09 Sep 2021 $0.3953 0.00% Final 24 Sep 2021
    04 Mar 2021 $0.0188 0.00% Supplemental 18 Mar 2021
    04 Mar 2021 $0.3506 0.00% Interim 18 Mar 2021
    24 Sep 2020 $0.0176 0.00% Supplemental 09 Oct 2020
    24 Sep 2020 $0.3289 0.00% Final 09 Oct 2020
    12 Mar 2020 $0.0165 0.00% Supplemental 03 Apr 2020
    12 Mar 2020 $0.3232 0.00% Interim 03 Apr 2020
    26 Sep 2019 $0.0163 0.00% Supplemental 11 Oct 2019
    26 Sep 2019 $0.3076 0.00% Final 11 Oct 2019
    14 Mar 2019 $0.0152 0.00% Supplemental 05 Apr 2019
    14 Mar 2019 $0.2920 0.00% Interim 05 Apr 2019
    27 Sep 2018 $0.2871 0.00% Final 12 Oct 2018
    15 Mar 2018 $0.0146 0.00% Supplemental 06 Apr 2018
    15 Mar 2018 $0.2766 0.00% Interim 06 Apr 2018
    28 Sep 2017 $0.0146 0.00% Supplemental 13 Oct 2017
    28 Sep 2017 $0.2664 0.00% Final 13 Oct 2017
    16 Mar 2017 $0.2453 0.00% Interim 07 Apr 2017
    29 Sep 2016 $0.2697 0.00% Final 14 Oct 2016
    10 Mar 2016 $0.2075 0.00% Interim 01 Apr 2016
    30 Sep 2015 $0.2024 0.00% Final 16 Oct 2015
    11 Mar 2015 $0.1884 0.00% Interim 02 Apr 2015
    01 Oct 2014 $0.1650 0.00% Final 17 Oct 2014
    12 Mar 2014 $0.1776 0.00% Interim 04 Apr 2014
    06 Apr 2011 $0.1350 0.00% Interim 21 Apr 2011
    08 Sep 2010 $0.1750 0.00% Final 08 Oct 2010
    15 Mar 2010 $0.1350 0.00% Interim 13 Apr 2010
    07 Sep 2009 $0.1450 0.00% Final 02 Oct 2009
    23 Mar 2009 $0.1050 0.00% Interim 21 Apr 2009
    15 Sep 2008 $0.0238 0.00% Supplemental 10 Oct 2008
    15 Sep 2008 $0.1350 0.00% Final 10 Oct 2008
    14 Apr 2008 $0.0168 0.00% Supplemental 09 May 2008
    14 Apr 2008 $0.0950 0.00% Interim 09 May 2008
    23 Oct 2007 $0.0229 0.00% Supplemental 26 Oct 2007
    23 Oct 2007 $0.1300 0.00% Final 26 Oct 2007
    16 Apr 2007 $0.0168 0.00% Supplemental 20 Apr 2007
    16 Apr 2007 $0.0950 0.00% Interim 20 Apr 2007
    24 Oct 2006 $0.0229 0.00% Supplemental 27 Oct 2006
    24 Oct 2006 $0.1300 0.00% Final 27 Oct 2006
    03 Apr 2006 $0.0168 0.00% Supplemental 07 Apr 2006
    03 Apr 2006 $0.0950 0.00% Interim 07 Apr 2006
    03 Oct 2005 $0.0221 0.00% Supplemental 07 Oct 2005
    03 Oct 2005 $0.1250 0.00% Final 07 Oct 2005
    14 Mar 2005 $0.0159 0.00% Supplemental 18 Mar 2005
    14 Mar 2005 $0.0900 0.00% Interim 18 Mar 2005

    EBO ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Ebos Group Ltd

    EBOS Group Ltd (ASX: EBO) is the largest pharmaceutical wholesaler and distributor across Australia, New Zealand, and Southeast Asia. The company provides pharmaceutical and wellness products to community pharmacies, public and private hospitals, day surgeries, general practices, aged care facilities, and specialist clinics.

    EBOS Group also operates an animal health product wholesale, manufacturing, and retail business, as well as providing third-party logistics services.

    The vast majority of the company's revenue derives from its services to community pharmacies and institutional healthcare providers, which accounts for about 80% of revenue. Its Australian operations similarly contribute around 80% of its total revenue.

     

    EBO Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Dec 2024 $33.14 $-0.08 -0.24% 250,058 $33.23 $33.33 $32.89
    19 Dec 2024 $33.22 $0.08 0.24% 79,015 $34.19 $34.19 $32.69
    18 Dec 2024 $33.14 $-0.41 -1.22% 69,641 $33.20 $33.28 $32.73
    17 Dec 2024 $33.55 $-0.02 -0.06% 20,508 $33.54 $33.60 $33.05
    16 Dec 2024 $33.57 $0.20 0.60% 16,849 $33.30 $33.59 $32.99
    13 Dec 2024 $33.37 $0.12 0.36% 30,584 $33.29 $33.59 $33.14
    12 Dec 2024 $33.25 $-0.15 -0.45% 19,448 $33.32 $33.36 $32.87
    11 Dec 2024 $33.40 $0.13 0.39% 23,556 $33.46 $33.50 $33.19
    10 Dec 2024 $33.27 $-0.25 -0.75% 12,971 $33.58 $33.66 $33.27
    09 Dec 2024 $33.52 $-0.47 -1.38% 44,452 $33.89 $33.93 $33.49
    06 Dec 2024 $33.99 $-0.21 -0.61% 20,117 $34.20 $34.26 $33.76
    05 Dec 2024 $34.20 $-0.28 -0.81% 10,853 $34.50 $34.62 $34.05
    04 Dec 2024 $34.48 $-0.39 -1.12% 12,709 $34.86 $34.86 $34.43
    03 Dec 2024 $34.87 $0.07 0.20% 36,395 $34.84 $34.98 $34.47
    02 Dec 2024 $34.80 $0.15 0.43% 19,532 $34.57 $35.06 $34.51
    29 Nov 2024 $34.65 $-0.13 -0.37% 17,753 $34.13 $34.79 $34.13
    28 Nov 2024 $34.78 $0.23 0.67% 15,179 $34.71 $34.86 $34.54
    27 Nov 2024 $34.55 $0.27 0.79% 42,712 $34.52 $34.89 $34.10
    26 Nov 2024 $34.28 $-0.30 -0.87% 40,377 $34.58 $34.58 $33.86
    25 Nov 2024 $34.58 $0.83 2.46% 80,920 $33.69 $34.58 $33.33
    22 Nov 2024 $33.75 $-0.08 -0.24% 24,457 $33.79 $34.16 $33.60
    21 Nov 2024 $33.83 $-0.07 -0.21% 43,840 $33.52 $34.00 $33.41

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    18 Sep 2024 Stuart McLauchlan Issued 43 $1,482
    Dividend Reinvestment Plan (DRP). NZ$
    22 Mar 2024 Stuart McLauchlan Issued 39 $1,390
    Dividend Reinvestment Plan (DRP). NZ$

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Elizabeth(Liz) Mary Coutts Non-Executive DirectorNon-Executive Chairman Nov 2013
    Ms Coutts is member of the Risk Committee. She is Chair of Oceania Healthcare Limited and 2degrees Group Limited, Director of EBOS Group subsidiaries in New Zealand and Member, Marsh New Zealand Advisory Board.
    Mr Mark Alan Bloom Non-Executive Director Sep 2022
    Mr Bloom is a member of the Risk Committee. He is a former director of Pacific Smiles Group Limited and Abacus Property Group. Mark has also held several senior finance roles, including being CFO and executive director for insurance and financial services companies Liberty Life, South Africa and Manulife Financial, Canada.
    Mr Stuart McLauchlan Non-Executive Director Jul 2019
    Mr McLauchlan is Chairman of the Risk Committee. He is also a governor of the New Zealand Sports Hall of Fame and a member of the Marsh New Zealand Advisory Board. He was formerly a director of Ngai Tahu Tourism Ltd.
    Dr Tracey Leigh Batten Non-Executive Director Jul 2021
    Dr Batten is currently Chair of the Accident Compensation Corporation and a non-executive director of Medibank Private Limited and Nanosonics Limited. She was previously a non-executive director of National Institute of Water and Atmospheric Research, Abano Healthcare Group Limited and various other healthcare related research institutes, charities and industry and government bodies. During her executive career she was Group CEO of Imperial College Healthcare NHS Trust in the United Kingdom, Group CEO of St Vincent's Health Australia, CEO of Eastern Health and CEO of Dental Health Services Victoria.
    Ms Julie Tay Non-Executive Director May 2023
    Ms Tay is currently a director of Sonova, a global hearing care solutions company, headquartered in Switzerland and listed on the Swiss stock exchange. She has over 30 years of experience in international executive and non-executive roles across consumer healthcare, medical devices, and digital healthcare. Julie was Senior Vice President and Managing Director, Asia Pacific, and member of the global Executive Management Committee for Align Technology. Prior to this time, she was regional head of Bayer Healthcare (Diabetes Care) in Asia Pacific and previously held senior executive roles in Asia at Johnson Diversey and Johnson & Johnson.
    Mr Andrew McLean Chief Executive Officer Aug 2024
    -
    Mr John Cullity Chief Executive Officer Jul 2014
    -
    Julie Dillon CEO Animal Care
    -
    Matt Muscio CEO Medical Technology
    -
    Brett Barons CEO Symbion
    -
    Andrew McLean Chief Executive Officer
    -
    John Cullity Chief Executive Officer
    -
    Leonard Hansen Chief Financial Officer
    -
    Mithran Naiker Chief Information Officer
    -
    David Lewis EGM
    -
    Simon Bunde EGM Strategic Operations ESG and Innovation
    -
    Martin Krauskopf EGM Strategy and Mergers and Acquisitions
    -
    Janelle Cain General Counsel
    -
    Jacinta McCarthy Group GM Human Resources
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Sybos Holdings Pte Limited 36,698,002 18.99%
    Custodial Services Limited 12,863,254 6.66%
    HSBC Nominees (New Zealand) Limited NZCSD 11,945,394 6.18%
    JP Morgan Chase Bank NA NZ Branch-Segregated Clients Acct NZCSD 10,313,439 5.34%
    BNP Paribas Nominees (NZ) Limited NZCSD 10,162,902 5.26%
    HSBC Nominees (New Zealand) Limited A/C State Street NZCSD 10,031,609 5.19%
    JP Morgan Nominees Australia Limited 9,884,811 5.12%
    Tea Custodians Limited Client Property Trust Account NZCSD 7,607,290 3.94%
    Forsyth Barr Custodians Limited 6,814,524 3.53%
    Accident Compensation Corporation NZCSD 5,567,722 2.88%
    Citibank Nominees (New Zealand) Limited NZCSD 5,393,354 2.79%
    FNZ Custodians Limited 4,771,289 2.47%
    HSBC Nominees A/C NZ Superannuation Fund Nominees Limited NZCSD 4,218,386 2.18%
    HSBC Custody Nominees (Australia) Limited 3,881,197 2.01%
    JBWere (NZ) Nominees Limited 2,556,423 1.32%
    ANZ Wholesale Australasian Share Fund NZCSD 2,504,047 1.29%
    New Zealand Depository Nominee Limited 2,385,485 1.23%
    Whyte Adder No 3 Limited 1,797,874 0.93%
    Generate Kiwisaver Public Trust nominees Limited <NZCSD> 1,642,442 0.85%
    Simplicity Nominees Limited NZCSD 1,566,940 0.81%

    Profile

    since

    Note